{"id":353403,"date":"2016-04-04T10:46:56","date_gmt":"2016-04-04T15:46:56","guid":{"rendered":"https:\/\/ability-fl-prod.internetbrands.com\/ability-law\/injury\/product-liability\/zelnorm.html"},"modified":"2024-05-15T14:54:19","modified_gmt":"2024-05-15T19:54:19","slug":"zelnorm","status":"publish","type":"page","link":"https:\/\/www.findlaw.com\/injury\/product-liability\/zelnorm.html","title":{"rendered":"Zelnorm: Health Risks and Legal Information"},"content":{"rendered":"\n
\n

Zelnorm: Health Risks and Legal Information<\/h1>\n\n
\n
\n By Christie Nicholson, J.D.<\/a> | Legally reviewed by Oni Harton, J.D.<\/a>\n | Last updated\n
\n \n <\/i>\n Legally Reviewed\n <\/summary>\n\n
\n

This article has been written and reviewed for legal accuracy, clarity, and style by FindLaw\u2019s team of legal writers and attorneys<\/a> and in accordance with our editorial standards<\/a>.<\/em><\/p>\n\n <\/div>\n <\/details>\n\n

\n \n <\/i>\n Fact-Checked\n <\/summary>\n\n
\n

The last updated date refers to the last time this article was reviewed by FindLaw or one of our contributing authors<\/a>. We make every effort to keep our articles updated. For information regarding a specific legal issue affecting you, please contact an attorney in your area<\/a>.<\/em><\/p>\n\n <\/div>\n <\/details>\n<\/section>\n\n\n

\n
\n
\n

Key Takeaways<\/h2>\n
\n
\n
\n
\n
\n

Zelnorm was a prescription drug used to treat irritable bowel syndrome with constipation (IBS-C) that was withdrawn from the market in 2007 and later discontinued in 2022. Patients who suffered harm from Zelnorm have legal options under product liability laws if the manufacturer failed to adequately warn about its risks.<\/p>\n<\/div>\n<\/div>\n<\/div>\n

<\/div>\n
<\/div>\n<\/div>\n<\/div>\n\n <\/div>\n <\/div>\n<\/div>\n\n\n

Zelnorm\u00a0was a prescription medication doctors prescribed for short-term treatment for women over 65 years of age with irritable bowel syndrome (IBS) and\u00a0constipation (IBS-C). They also gave it to patients of all ages who had chronic constipation.<\/p>\n

On March 30, 2007, the U.S. Food and Drug Administration (FDA) requested that Novartis Pharmaceuticals stop marketing Zelnorm\u00a0(tegaserod maleate<\/a>). The FDA made this decision after a new study found a higher chance of heart attack, stroke, and chest pain in patients taking Zelnorm.<\/p>\n

Novartis discontinued the drug but rereleased it in 2019. But as of 2022, it was no longer available due to business reasons.<\/p>\n

This page provides an overview of Zelnorm, its dangers, and the pharmaceutical company’s discontinuation of the drug. It also discusses legal options for people who became sick after using this drug.<\/p>\n

If you have been harmed by Zelnorm or another pharmaceutical, you have legal options. Contact a product liability attorney<\/a> near you to learn your legal options. An attorney can determine if you have a case and help pursue fair compensation.<\/p>\n

What Conditions Did Zelnorm Treat?<\/h2>\n

Doctors used Zelnorm to help women who suffered from severe constipation and irritable bowel syndrome<\/a> (IBS). Zelnorm was a serotoninergic neurogenetic modulator that increased serotonin levels in the large and small intestines.<\/p>\n

This drug worked by speeding up the movement of the patient’s stools through the bowels. Quicker bowel movements\u00a0helped reduce diarrhea and constipation.<\/p>\n

FDA Warnings to Zelnorm Patients<\/h2>\n

While the drug was still on the market, the FDA warned Zelnorm patients about several health risks associated with the drug. They urged patients to contact their healthcare providers to discuss other treatments.<\/p>\n

Some of the health issues the FDA warned about<\/a> included:<\/p>\n